Provider
Cablivi® (caplacizumab-yhdp) - Medicaid
Quantity Limit
Program effective Date: Jun 01, 2024
Search Results
Displaying 2311 - 2320 of 3661 results
Provider
Cablivi® (caplacizumab-yhdp) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2024
Provider
QP45-21 Medical Drug Update for Botulinum Toxins (Myobloc, Botox, Dysport, Xeomin) - Commercial Products
Program effective Date: May 26, 2021
Provider
P34-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 2, 2021
Program effective Date: Jun 01, 2021
Provider
P3R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Jun 01, 2021
Provider
2021 June Bulletins
Program effective Date: Jun 01, 2021
Provider
Fintepla® (fenfluramine) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2024
Provider
Cannabidiol - Medicaid
Prior Authorization
Program effective Date: Aug 01, 2024
Provider
Cannabidiol - Commercial
Prior Authorization
Program effective Date: Aug 01, 2024
Provider
QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021
Program effective Date: Jun 09, 2021